Skip to content
2000
Volume 16, Issue 6
  • ISSN: 1568-0096
  • E-ISSN: 1873-5576

Abstract

Cisplatin is one of the leading chemotherapy drugs currently used in clinical settings. However, its serious side effects and its resistance developed by tumor cells hinder its usage. To decrease its side effects and maintain anti-cancer efficiency, various cisplatin based formulations were developed. In this minireview, we summarized the recent progress of cisplatin delivery strategies, including direct delivery, prodrug delivery and combination delivery. Key challenges preventing the development of improved drug formulations were identified, and effective approaches to address these issues were discussed in the context of these recent works.

Loading

Article metrics loading...

/content/journals/ccdt/10.2174/1568009616666160328113006
2016-07-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/ccdt/10.2174/1568009616666160328113006
Loading

  • Article Type:
    Research Article
Keyword(s): Cisplatin; combination delivery; drug delivery; drug resistance; prodrug; tumor therapy
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test